Related Experiment Video
Updated: Apr 25, 2026

13:27
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
51.3K
Pneumonia. Treatment and diagnosis
Joshua T Mattila1, Michael J Fine, Andrew H Limper
11 Department of Microbiology and Molecular Genetics.
Annals of the American Thoracic Society
|August 23, 2014
Summary
Improving pneumonia care requires systematic improvements in healthcare delivery and diagnostics. Research explores new treatments, like the immunomodulatory compound forsythin, to combat this leading cause of mortality.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pharmacology
Background:
- Pneumonia is a significant cause of illness and death globally.
- Despite treatment advances, improving patient outcomes remains a challenge.
- Community-acquired pneumonia (CAP) affects many individuals, especially those with comorbidities.
Purpose of the Study:
- To review current strategies for diagnosing and treating pneumonia.
- To discuss challenges in pathogen identification and diagnostic test interpretation.
- To explore novel therapeutic approaches, including immunomodulatory agents.
Main Methods:
- Review of current guidelines for community-acquired pneumonia (CAP) and fungal pneumonia.
- Discussion of diagnostic modalities and their limitations.
- Presentation of emerging therapeutic strategies, including plant-derived compounds.
Main Results:
- Systematic improvements in healthcare processes can reduce CAP mortality.
- Accurate pathogen identification is crucial but complicated by diagnostic test variability.
- Forsytthin, an immunomodulatory compound, shows potential as a novel pneumonia treatment.
Conclusions:
- Multifaceted approaches, from institutional policies to molecular interventions, are vital for combating pneumonia.
- Enhanced diagnostic accuracy and novel therapies are key to reducing pneumonia's impact.
- Further research into immunomodulatory strategies may offer new avenues for pneumonia treatment.
Related Concept Videos
Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia III: Complications and Assessment
1.3K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Atypical Pneumonia
78
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
78
Pneumonia V: Nursing management and Prevention
4.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Pneumonia I: Introduction
20
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
20
Pneumonia I: Introduction
1.4K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K

